Voloridge Investment Management
IRWD icon

Voloridge Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Voloridge Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-239,832
Closed -$2.74M – 1249
2023
Q4 		$2.74M Buy
239,832
+126,235
+111% +$1.25M 0.01% 758
2023
Q3 		$1.09M Sell
113,597
-793,328
-87% -$7.78M 0.01% 1077
2023
Q2 		$9.65M Buy
906,925
+557,088
+159% +$5.99M 0.05% 468
2023
Q1 		$3.68M Buy
349,837
+222,291
+174% +$2.49M 0.02% 780
2022
Q4 		$1.58M Buy
+127,546
New +$1.45M 0.01% 1030
2022
Q3 		– Sell
-240,431
Closed -$2.77M – 1507
2022
Q2 		$2.77M Buy
240,431
+215,797
+876% +$2.54M 0.01% 901
2022
Q1 		$310K Buy
+24,634
New +$282K ﹤0.01% 1267
2021
Q2 		– Sell
-127,473
Closed -$1.43M – 1690
2021
Q1 		$1.43M Buy
127,473
+94,957
+292% +$1M 0.01% 925
2020
Q4 		$370K Buy
+32,516
New +$356K ﹤0.01% 1184
2020
Q2 		– Sell
-12,546
Closed -$127K – 1378
2020
Q1 		$127K Sell
12,546
-24,679
-66% -$290K ﹤0.01% 1013
2019
Q4 		$495K Buy
+37,225
New +$410K 0.01% 816

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Voloridge Investment Management's IRWD Position: Q1 2024 in Review

Voloridge Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 239,832 shares — an estimated $2.74M sold.

Voloridge Investment Management first reported a position in IRWD in Q4 2019 and held it in 11 quarters. The position peaked at $9.65M in Q2 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Voloridge Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 239,832 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $2.74M.
  • Voloridge Investment Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 11 quarters.
  • Voloridge Investment Management's Ironwood Pharmaceuticals position peaked at $9.65M in Q2 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Voloridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.